George D. Demetri, MD, Alexander Drilon, MD, and Brian Rubin, MD, PhD, discuss TRK fusion cancers in this CME/MOC/CC activity titled "Modern Diagnostics and Targeted Therapy for TRK Fusion Cancers: Pathology-Oncologist Collaboration in the Era of Precision Medicine." For the full presentation, downloadable Practice Aids, complete CME/MOC/CC information, and to apply for credit, please visit us at http://bit.ly/3cMJNcg. CME/MOC/CC credit will be available until July 30, 2021.